VIC Foundry, in collaboration with Sandia National Laboratories, is developing a self-contained isothermal nucleic acid amplification test to address an unmet need for at-home testing of COVID-19 infection. This...
Despite the challenges 2020 brought, we saw promising progress for VIC and our portfolio companies. Click Here to download the The Annual Report Executive Summary or view it below.
The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovation from global sources. We are pleased to highlight the...
SFC Fluidics Inc., developer of an Alternate Controller Enabled (ACE) insulin delivery pod and Diabeloop, pioneer in therapeutic artificial intelligence, are partnering to integrate the SFC ACE insulin pod into...
CardioWise, Inc., is pleased to announce Clearance of its 510(k) application by the US Food and Drug Administration (FDA) for its heart function analysis software, Stretch Quantifier for Endocardial Engraved Zones...
When I wrote my last “letter from the CEO” in January 2020, I did not foresee the tumultuous year ahead. For so many, it’s been a tragic and difficult year on a personal level. We have all been impacted by the pandemic...
CBSA President & CEO, Jennifer Jones Paton, asked Michael Artinger, PhD, Neurexis’ Chief Executive Officer, CBSA’s Key Questions for Life Sciences Innovators.
FEATURED RESOURCES
